CD274 and cancer: Pathway analysis of splenic cells identified inhibition of T cell exhaustion signaling and activation of Th1, PD-1/PD-L1 cancer immunotherapy, NK cell, and IL-7 signaling pathways among the most significant effects predicted with BET-i (Figure 1C and Supplemental Table 2).